PRESCRIPTION NONPRESCRIPTION MEDICINAL

Brand Owner (click to sort) Address Description
UNITED RESEARCH LABORATORIES MUTUAL PHARMACEUTICAL COMPANY, INC. 1100 ORTHODOX STREET PHILADELPHIA PA 19124 Prescription and nonprescription medicinal and pharmaceutical preparations including tablets and capsules for use in the treatment of diseases and ailments affecting the gastrointestinal tract, blood, cardiovascular system, skin, endocrine system, respiratory system, musculoskeletal system; full line of prescription and nonprescription medicinal and pharmaceutical preparations;RESEARCH LABORATORIES;
UNITED RESEARCH LABORATORIES UNITED RESEARCH LABORATORIES 1100 ORTHODOX STREET PHILADELPHIA PA 19124 Prescription and nonprescription medicinal and pharmaceutical preparations, namely, tablets and capsules for use in the treatment of diseases and ailments affecting the gastrointestinal tract, blood, cardiovascular system, skin, endocrine system, respiratory system, musculoskeletal system; full line of prescription and nonprescription medicinal and pharmaceutical preparations;RESEARCH LABORATORIES;
URL MUTUAL PHARMACEUTICAL COMPANY, INC. 1100 ORTHODOX STREET PHILADELPHIA PA 19124 Prescription and nonprescription medicinal and pharmaceutical preparations including tablets, capsules for use in the treatment of diseases and ailments affecting the gastrointestinal tract, blood, cardiovascular system, skin, endocrine system, respiratory system, musculoskeletal system; Full line of prescription and non-prescription medicinal and pharmaceutical preparations;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A method of preventing the headache phase of migraine in a human comprises administration of a 5HT1 receptor agonist or administration of an over-the-counter or nonprescription drug to said human exhibiting prodrome symptoms of migraine. Suitably, the method comprises administration of a migraine headache phase-preventing effective amount of the 5HT1 agonist or over-the-counter or nonprescription drug. There is disclosed a preemptive prophylaxis migraine method using the following cognitive tests: Simple Reaction Time; Running Memory Continuous Performance Task; Matching to Sample; Mathematical Processing Task; and interpreting the results as a percent of baseline indicator of need for prophylaxis.